<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> (BWS) is a clinically <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> <z:hpo ids='HP_0001548'>overgrowth</z:hpo> syndrome associated with an increased risk for <z:e sem="disease" ids="C0027654" disease_type="Neoplastic Process" abbrv="">embryonal tumor</z:e> development </plain></SENT>
<SENT sid="1" pm="."><plain>BWS provides an ideal model system to study epigenetic mechanisms </plain></SENT>
<SENT sid="2" pm="."><plain>This condition is caused by a variety of genetic or epigenetic alterations within two domains of imprinted growth regulatory genes on human chromosome 11p15 </plain></SENT>
<SENT sid="3" pm="."><plain>Molecular studies of BWS have provided important data with respect to epigenotype/genotype-phenotype correlations; for example, alterations of Domain 1 are associated with the highest risk for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development, specifically <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Further, the elucidation of the molecular basis for monozygotic twinning in BWS defined a critical period for imprint maintenance during pre-implantation embryonic development </plain></SENT>
<SENT sid="5" pm="."><plain>In the future, such molecular studies in BWS will permit enhanced medical management and targeted genetic counseling </plain></SENT>
</text></document>